{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:53:00Z","timestamp":1792882380062,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s12012-021-09654-1","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T07:06:30Z","timestamp":1619593590000},"page":"630-641","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ellagic Acid Prevents Ca2+ Dysregulation and Improves Functional Abnormalities of Ventricular Myocytes via Attenuation of Oxidative Stress in Pathological Cardiac Hypertrophy"],"prefix":"10.1007","volume":"21","author":[{"given":"Bilge E.","family":"Yamasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanju","family":"Mercan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orhan","family":"Erkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4807-7344","authenticated-orcid":false,"given":"Semir","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,28]]},"reference":[{"issue":"5","key":"9654_CR1","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1006\/jmcc.2001.1358","volume":"33","author":"JD Port","year":"2001","unstructured":"Port, J. D., & Bristow, M. R. (2001). Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure. Journal of Molecular and Cellular Cardiology, 33(5), 887\u2013905. https:\/\/doi.org\/10.1006\/jmcc.2001.1358","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"6","key":"9654_CR2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s11427-011-4183-9","volume":"54","author":"X Ma","year":"2011","unstructured":"Ma, X., Song, Y., Chen, C., Fu, Y., Shen, Q., Li, Z., & Zhang, Y. (2011). Distinct actions of intermittent and sustained \u03b2-adrenoceptor stimulation on cardiac remodeling. Science China Life Sciences, 54(6), 493\u2013501. https:\/\/doi.org\/10.1007\/s11427-011-4183-9","journal-title":"Science China Life Sciences"},{"issue":"4","key":"9654_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1113\/expphysiol.2004.027482","volume":"89","author":"DF Goldspink","year":"2004","unstructured":"Goldspink, D. F., Burniston, J. G., Ellison, G. M., Clark, W. A., & Tan, L. B. (2004). Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: The same or separate death pathways? Experimental Physiology, 89(4), 407\u2013416. https:\/\/doi.org\/10.1113\/expphysiol.2004.027482","journal-title":"Experimental Physiology"},{"issue":"1","key":"9654_CR4","doi-asserted-by":"publisher","first-page":"8001","DOI":"10.1038\/s41598-020-64949-7","volume":"10","author":"HC Joca","year":"2020","unstructured":"Joca, H. C., Santos-Miranda, A., Joviano-Santos, J. V., Maia-Joca, R. P. M., Brum, P. C., Williams, G. S. B., & Cruz, J. S. (2020). Chronic sympathetic hyperactivity triggers electrophysiological remodeling and disrupts excitation\u2013contraction coupling in heart. Scientific Reports UK, 10(1), 8001. https:\/\/doi.org\/10.1038\/s41598-020-64949-7","journal-title":"Scientific Reports UK"},{"issue":"6","key":"9654_CR5","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1161\/Circresaha.118.311403","volume":"123","author":"JL Wang","year":"2018","unstructured":"Wang, J. L., Gareri, C., & Rockman, H. A. (2018). G-protein-coupled receptors in heart disease. Circulation Research, 123(6), 716\u2013735. https:\/\/doi.org\/10.1161\/Circresaha.118.311403","journal-title":"Circulation Research"},{"issue":"5","key":"9654_CR6","doi-asserted-by":"publisher","first-page":"H792","DOI":"10.1152\/ajpheart.00017.2014","volume":"307","author":"WW Ding","year":"2014","unstructured":"Ding, W. W., Dong, M., Deng, J. X., Yan, D. W., Liu, Y., Xu, T., & Liu, J. (2014). Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway. American Journal of Physiology Heart and Circulatory Physiology, 307(5), H792\u2013H802. https:\/\/doi.org\/10.1152\/ajpheart.00017.2014","journal-title":"American Journal of Physiology Heart and Circulatory Physiology"},{"issue":"1","key":"9654_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1172\/Jci62834","volume":"123","author":"AR Marks","year":"2013","unstructured":"Marks, A. R. (2013). Calcium cycling proteins and heart failure: Mechanisms and therapeutics. Journal of Clinical Investigation, 123(1), 46\u201352. https:\/\/doi.org\/10.1172\/Jci62834","journal-title":"Journal of Clinical Investigation"},{"issue":"4","key":"9654_CR8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s00395-013-0360-2","volume":"108","author":"S Neef","year":"2013","unstructured":"Neef, S., & Maier, L. S. (2013). Novel aspects of excitation\u2013contraction coupling in heart failure. Basic Research in Cardiology, 108(4), 360. https:\/\/doi.org\/10.1007\/s00395-013-0360-2","journal-title":"Basic Research in Cardiology"},{"issue":"5","key":"9654_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10557-016-6687-9","volume":"30","author":"DD Wang","year":"2016","unstructured":"Wang, D. D., Shan, Y. G., Huang, Y., Tang, Y. H., Chen, Y. T., Li, R., Yang, J., & Huang, C. X. (2016). Vasostatin-1 stops structural remodeling and improves calcium handling via the eNOS-NO-PKG pathway in rat hearts subjected to chronic beta-adrenergic receptor activation. Cardiovascular Drugs and Therapy, 30(5), 455\u2013464. https:\/\/doi.org\/10.1007\/s10557-016-6687-9","journal-title":"Cardiovascular Drugs and Therapy"},{"key":"9654_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ceca.2017.09.002","volume":"67","author":"Y Olgar","year":"2017","unstructured":"Olgar, Y., Celen, M. C., Yamasan, B. E., Ozturk, N., Turan, B., & Ozdemir, S. (2017). Rho-kinase inhibition reverses impaired Ca2+ handling and associated left ventricular dysfunction in pressure overload-induced cardiac hypertrophy. Cell Calcium, 67, 81\u201390. https:\/\/doi.org\/10.1016\/j.ceca.2017.09.002","journal-title":"Cell Calcium"},{"issue":"1","key":"9654_CR11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.cardiores.2004.08.013","volume":"65","author":"GX Zhang","year":"2005","unstructured":"Zhang, G. X., Kimura, S., Nishiyama, A., Shokoji, T., Rahman, M., Yao, L., Nagai, Y., Fujisawa, Y., Miyatake, A., & Abe, Y. (2005). Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. Cardiovascular Research, 65(1), 230\u2013238. https:\/\/doi.org\/10.1016\/j.cardiores.2004.08.013","journal-title":"Cardiovascular Research"},{"issue":"1","key":"9654_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.metabol.2012.06.003","volume":"62","author":"MM Kannan","year":"2013","unstructured":"Kannan, M. M., & Quine, S. D. (2013). Ellagic acid inhibits cardiac arrhythmias, hypertrophy and hyperlipidaemia during myocardial infarction in rats. Metabolism, 62(1), 52\u201361. https:\/\/doi.org\/10.1016\/j.metabol.2012.06.003","journal-title":"Metabolism"},{"issue":"3","key":"9654_CR13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12012-013-9197-z","volume":"13","author":"MC Lin","year":"2013","unstructured":"Lin, M. C., & Yin, M. C. (2013). Preventive effects of ellagic acid against doxorubicin-induced cardio-toxicity in mice. Cardiovascular Toxicology, 13(3), 185\u2013193. https:\/\/doi.org\/10.1007\/s12012-013-9197-z","journal-title":"Cardiovascular Toxicology"},{"issue":"4","key":"9654_CR14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1177\/0960327117701986","volume":"37","author":"AA Hemmati","year":"2018","unstructured":"Hemmati, A. A., Olapour, S., Varzi, H. N., Khodayar, M. J., Dianat, M., Mohammadian, B., & Yaghooti, H. (2018). Ellagic acid protects against arsenic trioxide-induced cardiotoxicity in rat. Human and Experimental Toxicology, 37(4), 412\u2013419. https:\/\/doi.org\/10.1177\/0960327117701986","journal-title":"Human and Experimental Toxicology"},{"issue":"15","key":"9654_CR15","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1055\/a-0633-9492","volume":"84","author":"J-L R\u00edos","year":"2018","unstructured":"R\u00edos, J.-L., Giner, R. M., Mar\u00edn, M., & Recio, M. C. (2018). A pharmacological update of ellagic acid. Planta medica, 84(15), 1068\u20131093. https:\/\/doi.org\/10.1055\/a-0633-9492","journal-title":"Planta medica"},{"key":"9654_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/287534","author":"L Wang","year":"2013","unstructured":"Wang, L., Li, L., Ran, X., Long, M., Zhang, M., Tao, Y., Luo, X., Wang, Y., Ma, X., Halmurati, U., Mao, X., & Ren, J. (2013). Ellagic acid reduces adipogenesis through inhibition of differentiation-prevention of the induction of Rb phosphorylation in 3T3-L1 adipocytes. Evidence Based Complementary and Alternative Medicine. https:\/\/doi.org\/10.1155\/2013\/287534","journal-title":"Evidence Based Complementary and Alternative Medicine"},{"key":"9654_CR17","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.biopha.2017.07.106","volume":"95","author":"DZ Wei","year":"2017","unstructured":"Wei, D. Z., Lin, C., Huang, Y. Q., Wu, L. P., & Huang, M. Y. (2017). Ellagic acid promotes ventricular remodeling after acute myocardial infarction by up-regulating miR-140-3p. Biomedical Pharmacotherapy, 95, 983\u2013989. https:\/\/doi.org\/10.1016\/j.biopha.2017.07.106","journal-title":"Biomedical Pharmacotherapy"},{"issue":"4","key":"9654_CR18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10863-013-9514-z","volume":"45","author":"N Ozturk","year":"2013","unstructured":"Ozturk, N., Yaras, N., Ozmen, A., & Ozdemir, S. (2013). Long-term administration of rosuvastatin prevents contractile and electrical remodelling of diabetic rat heart. Journal of Bioenergetics and Biomembranes, 45(4), 343\u2013352. https:\/\/doi.org\/10.1007\/s10863-013-9514-z","journal-title":"Journal of Bioenergetics and Biomembranes"},{"issue":"2","key":"9654_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s12011-012-9350-8","volume":"148","author":"M Aydemir","year":"2012","unstructured":"Aydemir, M., Ozturk, N., Dogan, S., Aslan, M., Olgar, Y., & Ozdemir, S. (2012). Sodium tungstate administration ameliorated diabetes-induced electrical and contractile remodeling of rat heart without normalization of hyperglycemia. Biological Trace Element Research, 148(2), 216\u2013223. https:\/\/doi.org\/10.1007\/s12011-012-9350-8","journal-title":"Biological Trace Element Research"},{"key":"9654_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/978-1-59745-571-8_17","volume":"139","author":"LE Wold","year":"2007","unstructured":"Wold, L. E., & Ren, J. (2007). Mechanical measurement of contractile function of isolated ventricular myocytes. Methods in Molecular Medicine, 139, 263\u2013270. https:\/\/doi.org\/10.1007\/978-1-59745-571-8_17","journal-title":"Methods in Molecular Medicine"},{"issue":"5","key":"9654_CR21","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10557-015-6617-2","volume":"29","author":"M Kucuk","year":"2015","unstructured":"Kucuk, M., Celen, M. C., Yamasan, B. E., Olgar, Y., & Ozdemir, S. (2015). Effects of ticagrelor on ionic currents and contractility in rat ventricular myocytes. Cardiovascular Drugs and Therapy, 29(5), 419\u2013424. https:\/\/doi.org\/10.1007\/s10557-015-6617-2","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"4","key":"9654_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10863-016-9666-8","volume":"48","author":"N Ozturk","year":"2016","unstructured":"Ozturk, N., Olgar, Y., Aslan, M., & Ozdemir, S. (2016). Effects of magnesium supplementation on electrophysiological remodeling of cardiac myocytes in L-NAME induced hypertensive rats. Journal of Bioenergetics and Biomembranes, 48(4), 425\u2013436. https:\/\/doi.org\/10.1007\/s10863-016-9666-8","journal-title":"Journal of Bioenergetics and Biomembranes"},{"issue":"6","key":"9654_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1097\/Fjc.0000000000000153","volume":"64","author":"Y Olgar","year":"2014","unstructured":"Olgar, Y., Ozturk, N., Usta, C., Puddu, P. E., & Ozdemir, S. (2014). Ellagic acid reduces L-type Ca2(+) current and contractility through modulation of NO-GC-cGMP pathways in rat ventricular myocytes. Journal of Cardiovascular Pharmacology, 64(6), 567\u2013573. https:\/\/doi.org\/10.1097\/Fjc.0000000000000153","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"9654_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-021-09642-5","author":"N Ozturk","year":"2021","unstructured":"Ozturk, N., Uslu, S., Mercan, T., Erkan, O., & Ozdemir, S. (2021). Rosuvastatin reduces L-type Ca(2+) current and alters contractile function in cardiac myocytes via modulation of \u03b2-adrenergic receptor signaling. Cardiovascular Toxicology. https:\/\/doi.org\/10.1007\/s12012-021-09642-5","journal-title":"Cardiovascular Toxicology"},{"issue":"8","key":"9654_CR25","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1139\/Y09-053","volume":"87","author":"A Mikusova","year":"2009","unstructured":"Mikusova, A., Kralova, E., Tylkova, L., Novotova, M., & Stankovicova, T. (2009). Myocardial remodelling induced by repeated low doses of isoproterenol. Canadian Journal of Physiology and Pharmacology, 87(8), 641\u2013651. https:\/\/doi.org\/10.1139\/Y09-053","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"issue":"5","key":"9654_CR26","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/j.1476-5381.2009.00587.x","volume":"159","author":"JL Yeh","year":"2010","unstructured":"Yeh, J. L., Hsu, J. H., Wu, P. J., Liou, S. F., Liu, C. P., Chen, I. J., Wu, B. N., Dai, Z. K., & Wu, J. R. (2010). KMUP-1 attenuates isoprenaline-induced cardiac hypertrophy in rats through NO\/cGMP\/PKG and ERK1\/2\/calcineurin A pathways. British Journal of Pharmacology, 159(5), 1151\u20131160. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00587.x","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"9654_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s12012-011-9138-7","volume":"12","author":"MM Kannan","year":"2012","unstructured":"Kannan, M. M., & Quine, S. D. (2012). Mechanistic clues in the protective effect of ellagic acid against apoptosis and decreased mitochondrial respiratory enzyme activities in myocardial infarcted rats. Cardiovascular Toxicology, 12(1), 56\u201363. https:\/\/doi.org\/10.1007\/s12012-011-9138-7","journal-title":"Cardiovascular Toxicology"},{"issue":"1","key":"9654_CR28","first-page":"531","volume":"286","author":"B Linck","year":"1998","unstructured":"Linck, B., Boknik, P., Baba, H. A., Eschenhagen, T., Haverkamp, U., Jackel, E., Jones, L. R., Kirchhefer, U., Knapp, J., Laer, S., Muller, F. U., Schmitz, W., Scholz, H., Syska, A., Vahlensieck, U., & Neumann, J. (1998). Long-term beta adrenoceptor-mediated alteration in contractility and expression of phospholamban and sarcoplasmic reticulum Ca++-ATPase in mammalian ventricle. Journal of Pharmacology and Experimental Therapeutics, 286(1), 531\u2013538","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"9654_CR29","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0008-6363(98)00166-7","volume":"39","author":"M Suzuki","year":"1998","unstructured":"Suzuki, M., Ohte, N., Wang, Z. M., Williams, D. L., Little, W. C., & Cheng, C. P. (1998). Altered inotropic response of endothelin-1 in cardiomyocytes from rats with isoproterenol-induced cardiomyopathy. Cardiovascular Research, 39(3), 589\u2013599. https:\/\/doi.org\/10.1016\/S0008-6363(98)00166-7","journal-title":"Cardiovascular Research"},{"issue":"11","key":"9654_CR30","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.lfs.2007.07.022","volume":"81","author":"AJ Ferreira","year":"2007","unstructured":"Ferreira, A. J., Oliveira, T. L., Castro, M. C. M., Alvair, P. A., Castro, C. H., Caliari, M. V., Gava, E., Kitten, G. T., & Santos, R. A. S. (2007). Isoproterenol-induced impairment of heart function and remodeling are attenuated by the nonpeptide angiotensin-(1\u20137) analogue AVE 0991. Life Sciences, 81(11), 916\u2013923. https:\/\/doi.org\/10.1016\/j.lfs.2007.07.022","journal-title":"Life Sciences"},{"key":"9654_CR31","doi-asserted-by":"publisher","first-page":"34790","DOI":"10.1038\/srep34790","volume":"6","author":"Y Ryu","year":"2016","unstructured":"Ryu, Y., Jin, L., Kee, H. J., Piao, Z. H., Cho, J. Y., Kim, G. R., Choi, S. Y., Lin, M. Q., & Jeong, M. H. (2016). Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity. Scientific Reports UK, 6, 34790. https:\/\/doi.org\/10.1038\/srep34790","journal-title":"Scientific Reports UK"},{"issue":"1\u20132","key":"9654_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11010-017-3253-0","volume":"445","author":"N Saleem","year":"2018","unstructured":"Saleem, N., Prasad, A., & Goswami, S. K. (2018). Apocynin prevents isoproterenol-induced cardiac hypertrophy in rat. Molecular and Cellular Biochemistry, 445(1\u20132), 79\u201388. https:\/\/doi.org\/10.1007\/s11010-017-3253-0","journal-title":"Molecular and Cellular Biochemistry"},{"key":"9654_CR33","doi-asserted-by":"publisher","first-page":"108618","DOI":"10.1016\/j.biopha.2019.108618","volume":"112","author":"M Gan","year":"2019","unstructured":"Gan, M., Zheng, T., Shen, L., Tan, Y., Fan, Y., Shuai, S., Bai, L., Li, X., Wang, J., Zhang, S., & Zhu, L. (2019). Genistein reverses isoproterenol-induced cardiac hypertrophy by regulating miR-451\/TIMP2. Biomedical Pharmacotherapy, 112, 108618. https:\/\/doi.org\/10.1016\/j.biopha.2019.108618","journal-title":"Biomedical Pharmacotherapy"},{"issue":"7","key":"9654_CR34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura, M., & Sadoshima, J. (2018). Mechanisms of physiological and pathological cardiac hypertrophy. Nature Reviews Cardiology, 15(7), 387\u2013407. https:\/\/doi.org\/10.1038\/s41569-018-0007-y","journal-title":"Nature Reviews Cardiology"},{"issue":"4","key":"9654_CR35","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2174\/138161282104141204124129","volume":"21","author":"AT Roe","year":"2015","unstructured":"Roe, A. T., Frisk, M., & Louch, W. E. (2015). Targeting cardiomyocyte Ca2+ homeostasis in heart failure. Current Pharmaceutical Design, 21(4), 431\u2013448. https:\/\/doi.org\/10.2174\/138161282104141204124129","journal-title":"Current Pharmaceutical Design"},{"key":"9654_CR36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","volume":"97","author":"I Shimizu","year":"2016","unstructured":"Shimizu, I., & Minamino, T. (2016). Physiological and pathological cardiac hypertrophy. Journal of Molecular and Cellular Cardiology, 97, 245\u2013262. https:\/\/doi.org\/10.1016\/j.yjmcc.2016.06.001","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"3","key":"9654_CR37","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/01.cir.85.3.1046","volume":"85","author":"DJ Beuckelmann","year":"1992","unstructured":"Beuckelmann, D. J., Nabauer, M., & Erdmann, E. (1992). Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation, 85(3), 1046\u20131055. https:\/\/doi.org\/10.1161\/01.cir.85.3.1046","journal-title":"Circulation"},{"issue":"11","key":"9654_CR38","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1161\/01.Res.0000043663.08689.05","volume":"91","author":"MT Jiang","year":"2002","unstructured":"Jiang, M. T., Lokuta, A. J., Farrell, E. F., Wolff, M. R., Haworth, R. A., & Valdivia, H. H. (2002). Abnormal Ca2+ release, but normal ryanodine receptors, in canine and human heart failure. Circulation Research, 91(11), 1015\u20131022. https:\/\/doi.org\/10.1161\/01.Res.0000043663.08689.05","journal-title":"Circulation Research"},{"issue":"12","key":"9654_CR39","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1161\/01.RES.0000194329.41863.89","volume":"97","author":"X Ai","year":"2005","unstructured":"Ai, X., Curran, J. W., Shannon, T. R., Bers, D. M., & Pogwizd, S. M. (2005). Ca2+\/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure. Circulation Research, 97(12), 1314\u20131322. https:\/\/doi.org\/10.1161\/01.RES.0000194329.41863.89","journal-title":"Circulation Research"},{"issue":"39","key":"9654_CR40","doi-asserted-by":"publisher","first-page":"14104","DOI":"10.1073\/pnas.0504298102","volume":"102","author":"Z Kubalova","year":"2005","unstructured":"Kubalova, Z., Terentyev, D., Viatchenko-Karpinski, S., Nishijima, Y., Gyorke, I., Terentyeva, R., da Cunha, D. N. Q., Sridhar, A., Feldman, D. S., Hamlin, R. L., Carnes, C. A., & Gyorke, S. (2005). Abnormal intrastore calcium signaling in chronic heart failure. Proceedings of the National Academy of Sciences of USA, 102(39), 14104\u201314109. https:\/\/doi.org\/10.1073\/pnas.0504298102","journal-title":"Proceedings of the National Academy of Sciences of USA"},{"issue":"3","key":"9654_CR41","doi-asserted-by":"publisher","first-page":"H978","DOI":"10.1152\/ajpheart.00508.2010","volume":"300","author":"M Horiuchi-Hirose","year":"2011","unstructured":"Horiuchi-Hirose, M., Kashihara, T., Nakada, T., Kurebayashi, N., Shimojo, H., Shibazaki, T., Sheng, X. N., Yano, S., Hirose, M., Hongo, M., Sakurai, T., Moriizumi, T., Ueda, H., & Yamada, M. (2011). Decrease in the density of t-tubular L-type Ca2+ channel currents in failing ventricular myocytes. American Journal of Physiology Heart and Circulatory Physiology, 300(3), H978\u2013H988. https:\/\/doi.org\/10.1152\/ajpheart.00508.2010","journal-title":"American Journal of Physiology Heart and Circulatory Physiology"},{"key":"9654_CR42","first-page":"43","volume":"5","author":"J Fragoso-Medina","year":"2014","unstructured":"Fragoso-Medina, J., & Zarain-Herzberg, A. (2014). SERCA2a: Its role in the development of heart failure and as a potential therapeutic target. Research Reports in Clinical Cardiology, 5, 43\u201355","journal-title":"Research Reports in Clinical Cardiology"},{"issue":"1","key":"9654_CR43","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0008-6363(98)00241-7","volume":"41","author":"S Currie","year":"1999","unstructured":"Currie, S., & Smith, G. L. (1999). Enhanced phosphorylation of phospholamban and downregulation of sarco\/endoplasmic reticulum Ca2+ ATPase type 2 (SERCA 2) in cardiac sarcoplasmic reticulum from rabbits with heart failure. Cardiovascular Research, 41(1), 135\u2013146. https:\/\/doi.org\/10.1016\/S0008-6363(98)00241-7","journal-title":"Cardiovascular Research"},{"issue":"11","key":"9654_CR44","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.bbamcr.2006.08.025","volume":"1763","author":"P Vangheluwe","year":"2006","unstructured":"Vangheluwe, P., Sipido, K. R., Raleymaekers, L., & Wuytack, F. (2006). New perspectives on the role of SERCA2\u2019s Ca2+ affinity in cardiac function. BBA Molecular and Cellular Research, 1763(11), 1216\u20131228. https:\/\/doi.org\/10.1016\/j.bbamcr.2006.08.025","journal-title":"BBA Molecular and Cellular Research"},{"issue":"5","key":"9654_CR45","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.yjmcc.2007.03.738","volume":"42","author":"P Bhupathy","year":"2007","unstructured":"Bhupathy, P., Babu, G. J., & Periasamy, M. (2007). Sarcolipin and phospholamban as regulators of cardiac sarcoplasmic reticulum Ca2+ ATPase. Journal of Molecular and Cellular Cardiology, 42(5), 903\u2013911. https:\/\/doi.org\/10.1016\/j.yjmcc.2007.03.738","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"2","key":"9654_CR46","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/cvr\/cvq294","volume":"89","author":"M Shanmugam","year":"2011","unstructured":"Shanmugam, M., Gao, S. M., Hong, C., Fefelova, N., Nowycky, M. C., Xie, L. H., Periasamy, M., & Babu, G. J. (2011). Ablation of phospholamban and sarcolipin results in cardiac hypertrophy and decreased cardiac contractility. Cardiovascular Research, 89(2), 353\u2013361. https:\/\/doi.org\/10.1093\/cvr\/cvq294","journal-title":"Cardiovascular Research"},{"issue":"7","key":"9654_CR47","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.1074\/jbc.M508998200","volume":"281","author":"GJ Babu","year":"2006","unstructured":"Babu, G. J., Bhupathy, P., Petrashevskaya, N. N., Wang, H., Raman, S., Wheeler, D., Jagatheesan, G., Wieczorek, D., Schwartz, A., & Janssen, P. M. (2006). Targeted overexpression of sarcolipin in the mouse heart decreases sarcoplasmic reticulum calcium transport and cardiac contractility. Journal of Biological Chemistry, 281(7), 3972\u20133979. https:\/\/doi.org\/10.1074\/jbc.M508998200","journal-title":"Journal of Biological Chemistry"},{"issue":"25","key":"9654_CR48","doi-asserted-by":"publisher","first-page":"9199","DOI":"10.1073\/pnas.0402596101","volume":"101","author":"M Asahi","year":"2004","unstructured":"Asahi, M., Otsu, K., Nakayama, H., Hikoso, S., Takeda, T., Gramolini, A. O., Trivieri, M. G., Oudit, G. Y., Morita, T., Kusakari, Y., Hirano, S., Hongo, K., Hirotani, S., Yamaguchi, O., Peterson, A., Backx, P. H., Kurihara, S., Hori, M., & MacLennan, D. H. (2004). Cardiac-specific overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a) activity and impairs cardiac function in mice. Proceedings of the National Academy of Sciences of USA, 101(25), 9199\u20139204. https:\/\/doi.org\/10.1073\/pnas.0402596101","journal-title":"Proceedings of the National Academy of Sciences of USA"},{"issue":"4","key":"9654_CR49","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/j.yjmcc.2008.09.701","volume":"45","author":"I Namekata","year":"2008","unstructured":"Namekata, I., Ohhara, M., Hirota, Y., Fukumoto, M., Kawanishi, T., Takahara, A., & Tanaka, H. (2008). SERCA activators, ellagic acid and gingerol, ameliorate diabetes mellitus-induced diastolic dysfunction in isolated murine ventricular myocardia. Journal of Molecular and Cellular Cardiology, 45(4), S33","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"9","key":"9654_CR50","doi-asserted-by":"publisher","first-page":"U1150","DOI":"10.1161\/Circresaha.110.220418","volume":"107","author":"S Sossalla","year":"2010","unstructured":"Sossalla, S., Fluschnik, N., Schotola, H., Ort, K. R., Neef, S., Schulte, T., Wittkopper, K., Renner, A., Schmitto, J. D., Gummert, J., El-Armouche, A., Hasenfuss, G., & Maier, L. S. (2010). Inhibition of elevated Ca2+\/calmodulin-dependent protein kinase II improves contractility in human failing myocardium. Circulation Research, 107(9), U1150\u2013U1215. https:\/\/doi.org\/10.1161\/Circresaha.110.220418","journal-title":"Circulation Research"},{"issue":"12","key":"9654_CR51","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1161\/Circresaha.111.243956","volume":"110","author":"PD Swaminathan","year":"2012","unstructured":"Swaminathan, P. D., Purohit, A., Hund, T. J., & Anderson, M. E. (2012). Calmodulin-dependent protein kinase II: Linking heart failure and arrhythmias. Circulation Research, 110(12), 1661\u20131677. https:\/\/doi.org\/10.1161\/Circresaha.111.243956","journal-title":"Circulation Research"},{"issue":"8","key":"9654_CR52","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1161\/01.RES.0000069685.20258.F1","volume":"92","author":"LS Maier","year":"2003","unstructured":"Maier, L. S., Zhang, T., Chen, L., DeSantiago, J., Brown, J. H., & Bers, D. M. (2003). Transgenic CaMKII\u03b4C overexpression uniquely alters cardiac myocyte Ca2+ handling: reduced SR Ca2+ load and activated SR Ca2+ release. Circulation Research, 92(8), 904\u2013911. https:\/\/doi.org\/10.1161\/01.RES.0000069685.20258.F1","journal-title":"Circulation Research"},{"issue":"2","key":"9654_CR53","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1042\/BJ20031043","volume":"377","author":"S Currie","year":"2004","unstructured":"Currie, S., Loughrey, C. M., Craig, M.-A., & Smith, G. L. (2004). Calcium\/calmodulin-dependent protein kinase IIdelta associates with the ryanodine receptor complex and regulates channel function in rabbit heart. Biochemical Journal, 377(2), 357\u2013366. https:\/\/doi.org\/10.1042\/BJ20031043","journal-title":"Biochemical Journal"},{"key":"9654_CR54","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fphar.2014.00101","volume":"5","author":"E Camors","year":"2014","unstructured":"Camors, E., & Valdivia, H. H. (2014). CaMKII regulation of cardiac ryanodine receptors and inositol triphosphate receptors. Frontiers in Pharmacology, 5, 101. https:\/\/doi.org\/10.3389\/fphar.2014.00101","journal-title":"Frontiers in Pharmacology"},{"issue":"12","key":"9654_CR55","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1016\/S0735-1097(03)00471-6","volume":"41","author":"C Heymes","year":"2003","unstructured":"Heymes, C., Bendall, J. K., Ratajczak, P., Cave, A. C., Samuel, J. L., Hasenfuss, G., & Shah, A. M. (2003). Increased myocardial NADPH oxidase activity in human heart failure. Journal of American College of Cardiology, 41(12), 2164\u20132171. https:\/\/doi.org\/10.1016\/S0735-1097(03)00471-6","journal-title":"Journal of American College of Cardiology"},{"issue":"2","key":"9654_CR56","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1161\/Hypertensionaha.107.101980","volume":"51","author":"YH Looi","year":"2008","unstructured":"Looi, Y. H., Grieve, D. J., Siva, A., Walker, S. J., Anilkumar, N., Cave, A. C., Marber, M., Monaghan, M. J., & Shah, A. M. (2008). Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction. Hypertension, 51(2), 319\u2013325. https:\/\/doi.org\/10.1161\/Hypertensionaha.107.101980","journal-title":"Hypertension"},{"issue":"2","key":"9654_CR57","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1291\/hypres.31.325","volume":"31","author":"AH Polizio","year":"2008","unstructured":"Polizio, A. H., Balestrasse, K. B., Yannarelli, G. G., Noriega, G. O., Gorzalczany, S., Taira, C., & Tomaro, M. L. (2008). Angiotensin II regulates cardiac hypertrophy via oxidative stress but not antioxidant enzyme activities in experimental renovascular hypertension. Hypertension Research, 31(2), 325\u2013334","journal-title":"Hypertension Research"},{"issue":"1\u20132","key":"9654_CR58","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/s0009-8981(03)00003-2","volume":"329","author":"I Dalle-Donne","year":"2003","unstructured":"Dalle-Donne, I., Rossi, R., Giustarini, D., Milzani, A., & Colombo, R. (2003). Protein carbonyl groups as biomarkers of oxidative stress. Clinical Chimica Acta, 329(1\u20132), 23\u201338. https:\/\/doi.org\/10.1016\/s0009-8981(03)00003-2","journal-title":"Clinical Chimica Acta"},{"issue":"3\u20134","key":"9654_CR59","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00726-003-0011-2","volume":"25","author":"ER Stadtman","year":"2003","unstructured":"Stadtman, E. R., & Levine, R. L. (2003). Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids, 25(3\u20134), 207\u2013218. https:\/\/doi.org\/10.1007\/s00726-003-0011-2","journal-title":"Amino Acids"},{"issue":"1","key":"9654_CR60","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1152\/japplphysiol.00756.2014","volume":"118","author":"TS Bowen","year":"2015","unstructured":"Bowen, T. S., Mangner, N., Werner, S., Glaser, S., Kullnick, Y., Schrepper, A., Doenst, T., Oberbach, A., Linke, A., Steil, L., Schuler, G., & Adams, V. (2015). Diaphragm muscle weakness in mice is early-onset post-myocardial infarction and associated with elevated protein oxidation. Journal of Applied Physiology (1985), 118(1), 11\u201319. https:\/\/doi.org\/10.1152\/japplphysiol.00756.2014","journal-title":"Journal of Applied Physiology (1985)"},{"issue":"5\u20136","key":"9654_CR61","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1440-1681.2007.04591.x","volume":"34","author":"J Ren","year":"2007","unstructured":"Ren, J. (2007). Influence of gender on oxidative stress, lipid peroxidation, protein damage and apoptosis in hearts and brains from spontaneously hypertensive rats. Clinical and Experimental Pharmacology and Physiology, 34(5\u20136), 432\u2013438. https:\/\/doi.org\/10.1111\/j.1440-1681.2007.04591.x","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"issue":"8","key":"9654_CR62","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1161\/CIRCRESAHA.111.255216","volume":"111","author":"JR Burgoyne","year":"2012","unstructured":"Burgoyne, J. R., Mongue-Din, H., Eaton, P., & Shah, A. M. (2012). Redox signaling in cardiac physiology and pathology. Circulation Research, 111(8), 1091\u20131106. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.255216","journal-title":"Circulation Research"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-021-09654-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-021-09654-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-021-09654-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T16:17:14Z","timestamp":1626970634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-021-09654-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,28]]},"references-count":62,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["9654"],"URL":"https:\/\/doi.org\/10.1007\/s12012-021-09654-1","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,28]]},"assertion":[{"value":"11 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We wish to confirm that there are no known conflicts of interest associated with this publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the Akdeniz University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}